Healthcare provider profile · identity verified

Mario L Ceja, MD

Family Practice · CALEXICO, CA · NPI 1891753315

Profile state: partd only Open Payments: 2025 Medicare Part D: 2024 Last identity check: 2026-08-10 Page data build: 2026-08-12

Verified facts

What the public records show

We did not find matching Open Payments records for this doctor in 2025.

These records do not establish that a payment influenced prescribing or medical care.

Payment overview · 2025

General Payments

We did not find matching Open Payments records for this doctor in the selected program year.

Separate record types

Research & Ownership

Research Payments (direct recipient): not present in the loaded data

Associated Research Funding (for example, named PI): not present in the loaded data

Ownership / Investment: not present in the loaded data

These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.

Analysis 1 · Payment-linked products

Products named in Open Payments records

No payment-linked product analysis is available because no matching General Payment records were found for the selected year.

Public prescribing for products named in payments

There is no explicit payment-product set available for a Part D comparison.

The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.

Analysis 2 · Same-company prescribing overlap

Drugs reported in other payments from the same company that also appear in Medicare Part D

This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.

There is no payer-company set available for this comparison.

These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.

Public Medicare Part D data

Provider-and-drug rows loaded for 2024

Brand	Generic	Claims	Beneficiaries
Atorvastatin Calcium	Atorvastatin Calcium	1011	298
Metformin Hcl	Metformin Hcl	796	213
Amlodipine Besylate	Amlodipine Besylate	753	203
Omeprazole	Omeprazole	560	162
Rosuvastatin Calcium	Rosuvastatin Calcium	511	162
Losartan Potassium	Losartan Potassium	493	141
Levothyroxine Sodium	Levothyroxine Sodium	475	112
Metoprolol Succinate	Metoprolol Succinate	367	90
Tamsulosin Hcl	Tamsulosin Hcl	328	93
Alendronate Sodium	Alendronate Sodium	311	88
Pantoprazole Sodium	Pantoprazole Sodium	285	69
Losartan-Hydrochlorothiazide	Losartan/Hydrochlorothiazide	222	58
Lisinopril	Lisinopril	221	70
Furosemide	Furosemide	214	63
Gabapentin	Gabapentin	203	64
Simvastatin	Simvastatin	201	58
Meloxicam	Meloxicam	189	52
Ozempic	Semaglutide	189	37
Pioglitazone Hcl	Pioglitazone Hcl	189	53
Tramadol Hcl	Tramadol Hcl	188	54
Carvedilol	Carvedilol	181	47
Glimepiride	Glimepiride	176	51
Metoprolol Tartrate	Metoprolol Tartrate	170	53
Mirtazapine	Mirtazapine	167	40
Escitalopram Oxalate	Escitalopram Oxalate	163	43
Olmesartan Medoxomil	Olmesartan Medoxomil	154	36
Triamcinolone Acetonide	Triamcinolone Acetonide	152	65
Meclizine Hcl	Meclizine Hcl	147	50
Finasteride	Finasteride	141	33
Metformin Hcl Er	Metformin Hcl	136	38
Prednisone	Prednisone	135	109
Diclofenac Sodium	Diclofenac Sodium	132	45
Naproxen	Naproxen	130	63
Eliquis	Apixaban	127	34
Hydrochlorothiazide	Hydrochlorothiazide	125	28
Olmesartan-Hydrochlorothiazide	Olmesartan/Hydrochlorothiazide	117	33
Jardiance	Empagliflozin	115	27
Oxybutynin Chloride Er	Oxybutynin Chloride	113	36
Albuterol Sulfate Hfa	Albuterol Sulfate	108	32
Azithromycin	Azithromycin	99	90
Ibuprofen	Ibuprofen	90	35
Lorazepam	Lorazepam	90	19
Clopidogrel	Clopidogrel Bisulfate	89	28
Zolpidem Tartrate	Zolpidem Tartrate	88	19
Alprazolam	Alprazolam	87	21
Entresto	Sacubitril/Valsartan	86	24
Linzess	Linaclotide	85	26
Trazodone Hcl	Trazodone Hcl	85	31
Quetiapine Fumarate	Quetiapine Fumarate	84	18
Amlodipine Besylate-Benazepril	Amlodipine Besylate/Benazepril	76	21
Trulicity	Dulaglutide	75	16
Farxiga	Dapagliflozin Propanediol	71	18
Montelukast Sodium	Montelukast Sodium	71	15
Sertraline Hcl	Sertraline Hcl	71	20
Famotidine	Famotidine	69	19
Pravastatin Sodium	Pravastatin Sodium	69	21
Warfarin Sodium	Warfarin Sodium	65	suppressed
Nitrofurantoin Mono-Macro	Nitrofurantoin Monohyd/M-Cryst	63	44
Rybelsus	Semaglutide	63	15
Benazepril Hcl	Benazepril Hcl	61	21
Chlorthalidone	Chlorthalidone	61	18
Tradjenta	Linagliptin	61	suppressed
Allopurinol	Allopurinol	58	23
Bisoprolol Fumarate	Bisoprolol Fumarate	57	19
Ciprofloxacin Hcl	Ciprofloxacin Hcl	56	50
Valsartan	Valsartan	55	14
Celecoxib	Celecoxib	54	15
Mounjaro	Tirzepatide	52	suppressed
Amoxicillin-Clavulanate Potass	Amoxicillin/Potassium Clav	50	41
Toujeo Solostar	Insulin Glargine,hum.Rec.Anlog	50	suppressed
Hydralazine Hcl	Hydralazine Hcl	49	14
Basaglar Kwikpen U-100	Insulin Glargine,hum.Rec.Anlog	47	suppressed
Breyna	Budesonide/Formoterol Fumarate	47	11
Prolia	Denosumab	44	29
Duloxetine Hcl	Duloxetine Hcl	43	suppressed
Paxlovid	Nirmatrelvir/Ritonavir	43	43
Lantus Solostar	Insulin Glargine,hum.Rec.Anlog	42	13
Tizanidine Hcl	Tizanidine Hcl	40	22
Ondansetron Hcl	Ondansetron Hcl	38	18
Nitroglycerin	Nitroglycerin	37	suppressed
Sildenafil Citrate	Sildenafil Citrate	37	suppressed
Nifedipine Er	Nifedipine	36	14
Xarelto	Rivaroxaban	36	suppressed
Clonazepam	Clonazepam	35	suppressed
Symbicort	Budesonide/Formoterol Fumarate	35	12
Telmisartan	Telmisartan	35	suppressed
Fluticasone Propionate	Fluticasone Propionate	33	15
Sucralfate	Sucralfate	33	15
Januvia	Sitagliptin Phosphate	31	suppressed
Ramipril	Ramipril	30	11
Amitriptyline Hcl	Amitriptyline Hcl	29	suppressed
Bumetanide	Bumetanide	29	suppressed
Ezetimibe	Ezetimibe	29	11
Hydrocodone-Acetaminophen	Hydrocodone/Acetaminophen	29	suppressed
Enalapril Maleate	Enalapril Maleate	27	suppressed
Fenofibrate	Fenofibrate	27	suppressed
Potassium Chloride	Potassium Chloride	27	13
Memantine Hcl	Memantine Hcl	26	suppressed
Dutasteride	Dutasteride	25	suppressed
Lisinopril-Hydrochlorothiazide	Lisinopril/Hydrochlorothiazide	25	11
Paroxetine Hcl	Paroxetine Hcl	25	suppressed
Breo Ellipta	Fluticasone/Vilanterol	24	suppressed
Citalopram Hbr	Citalopram Hydrobromide	24	suppressed
Dicyclomine Hcl	Dicyclomine Hcl	24	suppressed
Megestrol Acetate	Megestrol Acetate	24	11
Myrbetriq	Mirabegron	24	suppressed
Valsartan-Hydrochlorothiazide	Valsartan/Hydrochlorothiazide	24	suppressed
Lactulose	Lactulose	23	suppressed
Oxybutynin Chloride	Oxybutynin Chloride	23	suppressed
Repaglinide	Repaglinide	23	suppressed
Ventolin Hfa	Albuterol Sulfate	23	suppressed
Vascepa	Icosapent Ethyl	22	suppressed
Levetiracetam	Levetiracetam	21	suppressed
Fluoxetine Hcl	Fluoxetine Hcl	20	suppressed
Irbesartan	Irbesartan	20	suppressed
Baclofen	Baclofen	19	suppressed
Acyclovir	Acyclovir	18	suppressed
Creon	Lipase/Protease/Amylase	18	suppressed
Terbinafine Hcl	Terbinafine Hcl	18	suppressed
Cephalexin	Cephalexin	17	15
Cholestyramine	Cholestyramine (With Sugar)	17	suppressed
Tresiba Flextouch U-200	Insulin Degludec	17	suppressed
Hydrocortisone	Hydrocortisone	16	12
Icosapent Ethyl	Icosapent Ethyl	16	suppressed
Fluconazole	Fluconazole	15	12
Hydroxyzine Hcl	Hydroxyzine Hcl	15	suppressed
Levofloxacin	Levofloxacin	15	13
Metronidazole	Metronidazole	15	14
Nano 2nd Gen Pen Needle	Pen Needle, Diabetic	15	suppressed
Procto-Med Hc	Hydrocortisone	15	suppressed
Bisoprolol-Hydrochlorothiazide	Bisoprolol/Hydrochlorothiazide	14	suppressed
Budesonide-Formoterol Fumarate	Budesonide/Formoterol Fumarate	14	suppressed
Colchicine	Colchicine	14	suppressed
Comfort Ez Pro Safety Pen Ndl	Pen Needle, Diabetic, Safety	14	suppressed
Estradiol	Estradiol	14	suppressed
Testosterone Cypionate	Testosterone Cypionate	14	suppressed
Torsemide	Torsemide	14	suppressed
Valacyclovir	Valacyclovir Hcl	14	suppressed
Clobetasol Propionate	Clobetasol Propionate	13	suppressed
Amoxicillin	Amoxicillin	12	11
Dapagliflozin	Dapagliflozin Propanediol	12	suppressed
Droplet Pen Needle	Pen Needle, Diabetic	12	suppressed
Fluticasone-Salmeterol	Fluticasone Propion/Salmeterol	12	suppressed
Isosorbide Mononitrate Er	Isosorbide Mononitrate	12	suppressed
Betamethasone Dipropionate	Betamethasone Dipropionate	11	suppressed
Donepezil Hcl	Donepezil Hcl	11	suppressed
Dulera	Mometasone/Formoterol	11	suppressed
Esomeprazole Magnesium	Esomeprazole Magnesium	11	suppressed
Fenofibrate	Fenofibrate,micronized	11	suppressed
Gemtesa	Vibegron	11	suppressed
Rizatriptan	Rizatriptan Benzoate	11	suppressed

Timeline

Payment and prescribing data by year

Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.

Year	General Payments	Main payer	Explicit products	Company overlaps	Part D coverage
2025	—	—	—	—	—
2024	—	—	—	—	Complete

Questions to ask

Questions you could discuss with your doctor

Are there reasonable alternatives I should understand when we discuss treatment options?
How should I interpret the industry-payment records shown here in the context of my care?

These are general questions generated from reviewed templates. They are not personalized medical advice.

Sources and limitations

How to read this page

Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.

Loaded source releases

Dataset	Year	Publication	Source
CMS Open Payments — General Payments	2025	2026-06-30	Original source
Medicare Part D Prescribers by Provider and Drug	2024	2026-05-06	Original source
NPPES Data Dissemination V2	current / reference data	2026-08-10	Original source

Methodology version: 2.1

Editorial template version: 2.4

Product contract version: 2.0

Schema version: 0.7.0

Page data build: 2026-08-12T23:34:59.370714+00:00

Publication policy: eligible for indexing after public-launch controls are enabled

Full methodology · Questions & answers · Report a possible error